MTOR and astrocytoma (excluding glioblastoma): As witnessed by multiple experimental and neuropathological findings, mTOR upregulation plays a major role in the development of the aggressive phenotype of glioblastoma (GBM, WHO grade IV astrocytoma), thus influencing prognosis and determining response to therapies.